Thomas LeBlanc

Advocacy In Action: The American Society Of Hematology (ASH) 2013
Feb
06
2014

Vital Options International presents Advocacy In Action®, bringing together cancer advocacy leadership to address: The Future of Genomics & Personalized Medicine, Cancer Care Planning & Palliative Care, and Public Policy & Issues Surrounding the Affordable Care Act (ACA) Joining Vital Options CEO, Selma Schimmel — The Future of Genomics & Personalized Medicine: Keith Stewart, MD, […]

Read More
Cancer Care Planning & Palliative Care: Defining & Redefining
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Cancer Care Planning & Palliative Care: Thomas LeBlanc, MD, Duke University Medical Center; Meghan Gutierrez, Lymphoma  Research Foundation (LRF); Scott Riccio, Leukemia and Lymphoma Society (LLS) In this segment the panel discusses the need for an evolution in the definition of palliative care and cancer care planning.

Read More
Cancer Care Planning & Palliative Care: Advocates & Clinicians Working Together
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Cancer Care Planning & Palliative Care: Thomas LeBlanc, MD, Duke University Medical Center; Meghan Gutierrez, Lymphoma  Research Foundation (LRF); Scott Riccio, Leukemia and Lymphoma Society (LLS) In this segment the panel discusses what the clinicians need from the advocate community to help with palliative care and cancer care […]

Read More
Cancer Care Planning & Palliative Care: Hematologic Treatment Side Effects
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Cancer Care Planning & Palliative Care: Thomas LeBlanc, MD, Duke University Medical Center; Meghan Gutierrez, Lymphoma  Research Foundation (LRF); Scott Riccio, Leukemia and Lymphoma Society (LLS) In this segment the panel discusses the hematologic treatment side effects associated with palliative care.

Read More